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Abstract
Background: The National Program for Quality Indicators in Community Healthcare in Israel (QICH) was developed
to provide policy makers and consumers with information on the quality of community healthcare in Israel. In
what follows we present the most recent results of the QICH indicator set for 2009 and an examination of changes
that have occurred since 2007.
Methods: Data for 28 quality indicators were collected from all four health plans in Israel for the years 2007-2009.
The QICH indicator set examined six areas of healthcare: asthma, cancer screening, cardiovascular health, child
health, diabetes and immunizations for older adults.
Results: Dramatic increases in the documentation of anthropometric measures were observed over the measurement
period. Documentation of BMI for adolescents and adults increased by 30 percentage points, reaching rates of 61% and
70%, respectively, in 2009. Modest increases (3%-7%) over time were observed for other primary prevention quality
measures including immunizations for older adults, cancer screening, anemia screening for young children, and
documentation of cardiovascular risks. Overall, rates of recommended care for chronic diseases (asthma, cardiovascular
disease and diabetes) increased over time. Changes in rates of quality care for diabetes were varied over the measurement
period.
Conclusions: The overall quality of community healthcare in Israel has improved over the past three years. Future
research should focus on the adherence to quality indicators in population subgroups and compare the QICH data
with those in other countries. In addition, one of the next steps in assessing and further improving healthcare
quality in Israel is to relate these process and performance indicators to health outcomes.
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Background
Performance indicators are often used to examine and
quantify the various components of healthcare, such as
effectiveness of care, safety, timeliness, patient-centered-
ness, access and efficiency [1]. Comparing indicator
results between healthcare systems allows administrators
and policy makers to learn “...from the many experi-
ences of others, drawing lessons on how to finance,
manage, and organize health care so as to improve
health system performance” [2]. The OECD describes its
Health Care Quality Indicator Project as an initiative to
be used “...to understand why differences exist and what
can be done to reduce those differences and improve
care in all countries” [3].
In March 2004 the Israel National Institute for Health
Policy and Health Services Research, with the support of
the Health Council inaugurated the National Program for
Quality Indicators in Community Healthcare in Israel
(QICH). This program began in 1999 as a research project
by Avi Porath, Gad Rabinovitch and Anat Raskin-Segal
from Ben-Gurion University. Its success has been, first
and foremost, a result of the full support and cooperation
of all four health plans between each other and with the
program in developing, assessing and publishing the
national quality indicators. Many of the QICH indicators
are based on definitions from existing international
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measures, such as those in the Healthcare Effectiveness
Data and Information Set (HEDIS) of the National Com-
mittee for Quality Assurance (NCQA) in the United
States, and with the intention of international comparison.
Since QICH’s establishment, four national reports on the
quality of healthcare in Israel have been published [4-7].
The primary goal of QICH is to provide policy makers
and consumers with aggregate information on the quality
of community healthcare in Israel in order to monitor
and improve the medical care system. The QICH indica-
tor set is based on national and international medical
guidelines that reflect the current scientific evidence.
Indicators are well-defined, measurable items agreed
upon by all stakeholders including health plans and pro-
fessional organizations. Data are systematically collected
for the entire population of Israel from all four health
plans to create national-level healthcare quality indicators
that are publically reported. In what follows is an over-
view of the results of the most recent QICH report with
specific attention to changes over time and implications
to the primary healthcare system in Israel.
Methods
Data source
Data for quality indicators are collected independently
by each of the four health plans for their insured popu-
lation. Each health plan maintains individual-level elec-
tronic data records that include medical appointments,
procedures, laboratory test results and pharmacy claims.
Quality indicators sent by each of the four health plans
are aggregated and these values (numerators and
denominators) are used to calculate national rates.
Coordination, data compilation, validation and quality
assessment and analysis of the national indicators are
performed by the program directorate.
Population
All Israeli residents are included in the data set. The
quality indicators presented represent the time period
2007 through 2009. Electronic records were unavailable
for a small percent of the population (< 1%). In addition,
individuals whose membership in the plan was less than
the full calendar year were excluded from the calcula-
tions. In 2009, for example, approximately 106,800 peo-
ple or 1.4% of the insured population from the previous
year switched healthcare plan [8] and did not have the
required data for a complete measurement year. It is
noteworthy that soldiers, largely comprised of indivi-
duals aged 18-21 years, are not covered by the health
plans since their medical care is delivered by the mili-
tary. Aside from these exceptions, the report includes
the entirety of Israel’s population, approximately seven
million people.
Quality indicators and data
Quality indicators were created with the consensus of the
four health plans and Israeli medical associations. The
HEDIS indicator set was used as a guide for the QICH
indicator definitions. The QICH indicator set reflects a
careful selection process that assessed the feasibility of
production and the applicability and significance of the
indicators for the healthcare system in Israel. Data were
collected according to gender and age group. Six areas of
healthcare - asthma, cancer screening, immunizations for
older adults, child health, cardiovascular health and dia-
betes were used to assess the quality of community health-
care in Israel. Twenty-eight QICH indicators are presented
for the years 2007-2009 (Figure 1). Identification of indivi-
duals with asthma and diabetes was according to phar-
macy claims. Patients with cardiovascular disease were
identified according to cardiac intervention - bypass sur-
gery or coronary angioplasty. It should be noted, that
these procedures were the only available diagnostic indica-
tors of cardiovascular disease accessible to all health plans
and therefore the number of patients included in this sub-
population reflect a small percentage of individuals with
the disease. Immunization status was established using
pharmacy claims (i.e., vaccine purchase).
Data quality assessment as well as performance audits
were carried out in three stages: by each health plan, by
the QICH program directorate and by an accredited exter-
nal auditor. Data checks that included logical tests for
negative numbers, unit tests, and valid numerator and
denominator entries as well as tests examining subgroups
and changes over time were performed by each health
plan internally and by the QICH program directorate. An
external auditor conducted a procedural audit for each
health plan as well as the for the QICH directorate. A sys-
tem-oriented approach to examining the proper function-
ing and management of the program was performed and
documented in comprehensive performance reports.
Rate differences were calculated as the absolute differ-
ence in percentage points between the rate in 2007 and
2009.
Results
Table 1 provides details for the definition and calculation
of each of the 28 quality indicators, the target population,
measurement period and the relevant data sources.
Table 2 presents the changes in the quality indicators
over the period 2007-2009. Both absolute and relative
changes are provided in the table.
Asthma
Rates of appropriate use of asthma control medication
for individuals with persistent asthma increased over the
three-year period and influenza immunization for this
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group increased to a rate of 40% by 2009 (absolute
increase of 11%).
Cancer screening
In 2009, the mammography rate for women over 51-74
years reached 68% and fecal occult blood test rate for
colon cancer (excluding those who underwent a colono-
scopy during the past five years) for individuals aged 50-74
years was 27%. Absolute rate increases of 5%-7% were
observed for both types of cancer screening over the
three-year measurement period.
Cardiovascular health
Quality measures of primary prevention of cardiovascu-
lar disease, which included BMI (adults) and blood pres-
sure documentation, increased to rates of 70% and 84%,
respectively, for the 3.8 million Israeli adult target popu-
lation aged 20-74 years. Rates of cholesterol documenta-
tion and control were 81% and 72%, respectively, for
Israeli adults, ages 35-74 years.
Measures of appropriate treatment and effectiveness of
treatment improved over the measurement period. For
example, rates of use of medications, such as beta block-
ers and statins, for individuals following a coronary
heart event were over 70%. The rate of appropriate con-
trol of cholesterol for cardiac heart patients was 72% in
2009; this represented an absolute change during the
three-year period of +3.5%.
Over the three-year measurement period, positive
changes in rates for cardiovascular care were observed for
all aspects of treatment - prevention, care and effectiveness
of care. In particular, substantial increases were observed
for documentation rates of body mass index for adoles-
cents and adults. For adolescents, rates of documentation
of height and weight increased dramatically from 28% in
2007 to 61% in 2009, while for adults, these rates rose 26
percentage points over the same time period.
Child health
An indicator of quality of healthcare for primary preven-
tion for children was examined. In 2009, 74% of chil-
dren 1-year of age underwent anemia screening - an
absolute increase of 7% from 2007.
Diabetes
Quality indicators for diabetes assessed both the provi-
sion and the effectiveness of care. Patients with diabetics
mellitus received basic recommended care, such as glu-
cose, blood pressure and cholesterol assessment
(> 90%), BMI documentation (84%), kidney function
testing (74%) and eye care documentation (64%). Only
about half the population of diabetics received an influ-
enza immunization in the winter season. Individuals
with diabetes mellitus who attained adequate glycemic
control (HbA1c ≤ 7%) decreased slightly over the mea-
surement period (49% to 48%) and remained stable
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Figure 1 Quality indicators of the National Program for Quality Indicators in Community Healthcare in Israel, 2007-2009.
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Table 1 Definitions and data sources of the QICH indicator set, 2007-2009.
Healthcare quality indicators Domain Data sourcea Target population
Asthma
Use of appropriate control medication for individuals with persistent asthmab
Percentage of individuals with persistent asthma who purchased at least three asthma control
medications in three different months during the measurement year
Treatment Pharmacy claims 5-56 years
Influenza vaccination for individuals with persistent asthmab
Percentage of individuals with persistent asthma who received the influenza vaccination during
the winter months of the measurement year (plus two months of subsequent year)
Treatment Pharmacy claims 5-56 years
Cancer screening
Breast cancer screening: Mammography
Percentage of women who had a mammogram during the past two years
Primary
prevention
Test records 51-74 years
Colon cancer screening: Fecal occult blood test
Percentage of individuals who had a fecal occult blood test during the measurement yearc
Primary
prevention
Laboratory results 50-74 years
Cardiovascular health
Blood pressure documentation
Percentage of individuals with blood pressure documentation
Primary
prevention
Medical records 20-54 years - documentation during past five years;
55-74 years - documentation during measurement year
Blood pressure assessment
Percentage of individuals with adequate blood pressure control (≤ 140/90 mmHg)
Primary
prevention
Medical records 20-54 years - documentation during past five years;
55-74 years - documentation during measurement year
Body mass index (BMI) documentation
• Percentage of individuals with BMI documentation - adolescents
• Percentage of individuals with BMI documentation - adults
Primary
prevention
Medical records 14-18 years - documentation during past three years;
20-64 years - documentation during past five years;
65-74 years - documentation of weight during the
measurement year and height during the past five years
Cholesterol documentation
Percentage of individuals with cholesterol documentation
Primary
prevention
Laboratory results 35-54 years - documentation during past five years;
55-74 years - documentation during measurement year
Cholesterol assessment
Percentage of individuals with adequate low-density lipoprotein cholesterol control (≤ 130 mg/dL)
Primary
prevention
Laboratory results 35-54 years - documentation during past five years;
55-74 years - documentation during measurement year
Treatment with statins and other low-density lipoprotein (LDL) modifying medications following a
coronary interventiond
Percentage of individuals following a coronary event who purchased at least three LDL-modifying




Treatment with angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers
(ARB) following a coronary interventiond
Percentage of individuals following a coronary event who purchased at least three ACEI/ARB




Treatment with beta blockers following a coronary interventiond
Percentage of individuals following a coronary event who purchased at least three ACEI/ARB




Cholesterol assessment following a coronary interventiond
Percentage of individuals following a coronary event with adequate cholesterol control (≤ 100







Anemia screening in infants
Percentage of children who had a hemoglobin test during the measurement year
Primary
prevention

















Table 1 Definitions and data sources of the QICH indicator set, 2007-2009. (Continued)
Diabetes
Blood pressure documentation
Percentage of patients with diabetes mellitus with blood pressure documentation during the
measurement year
Treatment Laboratory results 18+ years
Body mass index (BMI) documentation
Percentage of patients with diabetes mellitus with BMI documentation
Treatment Medical records 18+ years - documentation of weight during the
measurement year and height over the past five years
Cholesterol documentation
Percentage of patients with diabetes mellitus with cholesterol documentation during the
measurement year
Treatment Laboratory results All ages
Eye care documentation
Percentage of patients with diabetes mellitus with documentation of an eye examination during
the measurement year
Treatment Medical records All ages
Glycemic control documentation
Percentage of patients with diabetes mellitus with glycemic control (HbA1c) documentation
during the measurement year
Treatment Laboratory results All ages
Kidney function documentation
Percentage of patients with diabetes mellitus with microalbuminurea documentation during the
measurement year
Treatment Laboratory results All ages
Influenza vaccination
Percentage of patients with diabetes mellitus who received the influenza vaccination during the
winter months of the measurement year (plus two months of subsequent year)
Treatment Pharmacy claims 5+ years
Blood pressure assessment
Percentage of patients with diabetes mellitus with adequate blood pressure control (≤ 130/80
mmHg) during the measurement year
Effectiveness
of care
Medical records 18+ years
Cholesterol assessment
Percentage of patients with diabetes mellitus with adequate low-density lipoprotein cholesterol
control (≤ 100 mg/dL) during the measurement year
Effectiveness
of care
Laboratory results All ages
Glycemic control assessment




Laboratory results All ages
Assessment of inadequate glycemic control
Percentage of patients with diabetes mellitus with inadequate glycemic control (HbA1c > 9%)
during the measurement year
Effectiveness
of care
Laboratory results All ages
Treatment with insulin for individuals with inadequate glycemic control
Percentage of patients with diabetes mellitus with inadequate glycemic control (HbA1c > 9%) and






Immunizations for older adults
Influenza vaccination for older adults
Percentage of older adults who received the influenza vaccination during the winter months of
the measurement year (plus two months of subsequent year)
Primary
prevention
Pharmacy claims 65+ years
BMI, body mass index; LDL, low density lipoproteins; ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; HbA1c, glycated hemoglobin; QICH, National Program for Quality Indicators in
Community Healthcare in Israel
aAll data were collected from each MCO’s electronic records. Numerator and denominator data for each measure were collected by the National QICH project to create the national rate.
b Persistent asthma is defined by asthma medication purchases. These medications include control medication (immunomodulators, inhaled corticosteroids, leukotriene modifiers, long-acting beta-2 agonists,
methylxanthines, mast cell stabilizers), as well as relief medications (short-acting beta-2 agonists, anticholinergics).
c Excluding those who underwent a colonoscopy during the past five years.

















Table 2 Rates and change over time in the QICH indicator set, 2007-2009.
Healthcare quality indicators Denominator
populationa
Rates Rate differenceb Rate change (%)b
2007 2008 2009
Asthma
Treatment: influenza vaccination for individuals with persistent asthma 51,931 29.1% 31.6% 40.0% +10.9 37.5
Treatment: Use of appropriate control medication for individuals with persistent asthma 51,931 76.2% 78.1% 79.7% +3.5 4.6
Cancer
Primary prevention: breast cancer screening - mammography 695,621 60.7% 64.7% 67.7% +7.0 11.5
Primary prevention: colon cancer screening - fecal occult blood test 1,078,021 22.1% 24.4% 27.4% +5.3 24.0
Cardiovascular health
Primary prevention: body mass index documentation (adolescents) 511,374 27.9% 46.3% 60.8% +32.9 117.9
Primary prevention: body mass index documentation (adults) 3,719,937 43.9% 56.6% 69.7% +25.8 58.8
Primary prevention: blood pressure documentation 3,755,235 72.8% 78.3% 83.5% +10.7 14.7
Effectiveness of care: cholesterol assessment of adequate control following cardiac intervention 56,726 68.6% 71.4% 72.1% +3.5 5.1
Treatment: treatment with ACEI/ARB following cardiac intervention 65,299 63.1% 64.7% 66.4% +3.3 5.2
Primary prevention: cholesterol documentation 2,575,726 77.4% 79.0% 80.5% +3.1 4.0
Primary prevention: cholesterol assessment of adequate control 2,072,458 68.9% 70.9% 71.7% +2.8 4.1
Treatment: treatment with beta blockers following cardiac intervention 65,299 68.4% 67.9% 70.2% +1.8 2.6
Primary prevention: blood pressure assessment of adequate control 3,135,531 92.9% 93.6% 94.1% +1.2 1.3
Treatment: treatment with statins and other LDL modifying medications following a cardiac intervention 65,299 84.2% 83.8% 84.6% +0.4 0.5
Child health
Primary prevention: anemia screening for infants 151,741 66.4% 70.5% 73.5% +7.1 10.7
Diabetes
Treatment: BMI documentation 320,275 74.4% 81.3% 83.6% +9.2 12.4
Effectiveness of care: treatment of inadequate glycemic control 39,514 44.8% 48.8% 53.1% +8.2 18.5
Treatment: influenza vaccination 332,706 47.1% 51.4% 55.0% +7.9 16.8
Effectiveness of care: cholesterol - adequate control 300,885 60.3% 63.7% 65.6% +5.3 8.8
Treatment: kidney function documentation 332,854 71.3% 70.4% 74.3% +3.0 4.2
Treatment: blood pressure documentation 330,437 90.0% 91.9% 91.9% +1.9 2.1
Effectiveness of care: blood pressure - adequate control 303,710 67.0% 68.5% 68.6% +1.6 2.4
Treatment: eye care documentation 332,854 63.0% 63.5% 64.3% +1.3 2.1
Treatment: glycemic control documentation 332,854 91.7% 91.6% 92.3% +0.6 0.7
Effectiveness of care: glycemic control - inadequate controlc 307,244 13.3% 13.5% 12.9% -0.4 -3.0
Treatment: cholesterol documentation 332,854 90.9% 90.3% 90.4% -0.5 -0.6
Effectiveness of care: glycemic control - adequate control 307,244 49.4% 47.9% 48.0% -1.4 -2.8
Immunizations for older adults
Primary prevention: influenza vaccination for older adults 709,755 51.9% 55.3% 56.7% +4.8 9.2
BMI, body mass index; LDL, low density lipoproteins; ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; QICH, National Program for Quality Indicators in Community Healthcare in
Israel
aThe denominator population are all eligible individuals in 2009.
bThe numbers represent absolute differences in percentage points from 2007 to 2009 or changes relative to 2007.

















among those with poor glycemic control (13%). The
percent of individuals with diabetes mellitus who
reached pre-specified cholesterol and blood pressure tar-
gets showed an increase of 5.3% and 1.6% respectively.
Immunizations for older adults
The rates of influenza vaccination, a quality indicator of
preventive care among Israelis 65+ years, increased over
the measurement period from 52% to 57%.
Discussion
Overall, the quality in community healthcare in Israel as
measured by the QICH indicator set has improved over
the past three years. Increased levels of quality of care
were observed across almost all categories of health as
well as type of care - primary prevention, treatment and
effectiveness of care.
It should be noted that there are no set target standards
for quality measures in community healthcare in Israel.
Nevertheless, results from similar international indicators
are used as benchmarks for comparison and learning
tools for quality improvement [9]. Moreover, the QICH
indicator set is based on HEDIS definitions, which
strengthens the validity of the measures and encourages
comparison. International comparisons are complicated,
however, by numerous factors such as differences
between healthcare structures and measure definitions
[10,11]. For example, variations exist between measure
specifications (e.g., age limits), disease definition (e.g.,
based on physician diagnosis, hospital discharge data
and/or pharmacy records), reporting period and data col-
lection methods (e.g., self-reported data versus physician
documentation). The HEDIS program, for instance, col-
lects data from three different healthcare provider types -
Medicaid, Medicare and commercial insurers. Differences
between countries may also arise from variations in
guidelines of care, type and mode of care and resources
allocated for care. For example, Israel’s quality indicators
are used as healthcare surveillance tools while the Quality
and Outcomes Framework (QOF) in England is a perfor-
mance-based indicator system that rewards good
practice.
Quality indicators for primary prevention
The most dramatic increases in the QICH indicator set
2007-2009 were observed for documentation of anthro-
pometric measures. Documentation rates for height and
weight for the calculation of BMI among adolescents
and adults increased by approximately 30% over this
time period to rates of 61% and 70%, respectively. Rates
in Israel are high relative to adult BMI screening rates
in the United States (e.g., 35% for Medicaid and 41% for
commercially insured populations) [12].
Moderate increases over time were observed for other
primary prevention QICH measures, including immuni-
zations for older adults, cancer screening, anemia screen-
ing and documentation of cardiovascular risk factors
such as blood pressure and cholesterol. Comparison of
these measures with those in other healthcare systems
reveals wide variations in rates between countries. For
example, the rate of influenza immunization for older
adults in Israel in 2009 was 57%, similar to that of Ireland
and Luxembourg and in contrast to higher rates in Mex-
ico (88%) and France (71%) and lower rates in Finland
(43%) and Hungary (32%) [13]. Mammography screening
rates in Israel were similar to those of the OECD (68%
versus 62%, respectively), although substantial variations
exist between countries - high mammography rates in
Finland (86%) and Ireland (78%) and low rates in France
(47%) and Japan (24%) [14]. Anemia screening is not rou-
tinely conducted in most Western countries thereby pre-
venting comparisons. Recently released guidelines of the
American Academy of Pediatrics recommend universal
screening for anemia for children 12 months of age to
determine hemoglobin concentrations for the assessment
of iron deficiency [15]. This step may generate future
comparisons. Finally, documentation of cardiovascular
risk factors, such as cholesterol and blood pressure levels,
is essential for evaluating an individual’s risk of heart dis-
ease [16]. Documentation rates of these factors have
increased between 4%-15% from 2007 to 2009 and likely
reflect the increased attention of the healthcare system to
cardiovascular risks.
Quality indicators for chronic disease
Rates of recommended care for three chronic conditions
- asthma, cardiovascular disease and diabetes improved
over the measurement period and are nearing those in
other Western countries [12,17]. For example, appropri-
ate use of control medication for individuals with persis-
tent asthma improved by four percentage points
between 2007 and 2009; these rates remain lower than a
similar HEDIS quality indicator (91%) [12].
For indicators assessing care of patients with cardio-
vascular disease, at least 70% of Israelis following a cor-
onary intervention received the recommended treatment
with statins, beta blockers or ACEI/ARBs. For patients
following a coronary intervention, similarities between
Israel and England were observed for treatment with
beta blockers (Israel = 70%; England = 74%) but differed
for treatment with ACEI/ARB (Israel = 69%; England =
89%) [17]. Notably the QICH indicator set defined cor-
onary intervention as persons who underwent bypass
surgery or coronary angioplasty in the past five years,
while the QOF was based on patients who had a history
of myocardial infarction since April 2003.
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Treatment and care for diabetes in Israel has moved in
a positive direction over the three year measurement per-
iod, although changes in rates for indicators of glycemic
control were relatively small and even negative. Seven
indicators of adherence to recommended treatment of
diabetes mellitus were assessed. For the measurement
period 2007-2009, higher rates (≥ 74%) of appropriate
care were noted in four measures - documentation of
BMI, kidney function, glycemic control and cholesterol,
and relatively moderate rates (55%-74%) were observed
in the remaining three areas - documentation of blood
pressure and eye care and influenza immunization. The
observed trends for adequate glycemic control (< 7%) are
noteworthy. The results suggest that the practice of tight
glycemic control may be changing among primary care
physicians from a generalized HbA1c goal to an indivi-
dualized target. Indeed, recent studies have shown that
glycemic control for all patients with Type 2 diabetes
may not provide the ultimate benefit [18]. One of the
current goals of the QICH program is to revise this mea-
sure and determine sub-group-specific HbA1c goals.
Decreases, albeit slight, in inadequate glycemic control
(> 9%) indicate improvements in diabetes care. Further
monitoring is necessary to identify long-term trends.
Comparison with similar indicators and age groups from
the HEDIS and England reveal moderate variations
between countries and measures [12,17]. For example,
documentation of HbA1c among adults ranged from 92%
in Israel, 97% in the England and 89% in the United
States [12,17]. Similarly, rates of microalbuminurea test-
ing (kidney function) varied from 74% in Israel, 89% in
the England and 84% in the United States [12,17].
Quality indicators and policy
Improvements in quality of care have been noted pre-
viously in Israel [19]. In this recent study, the authors
hypothesize that quality improvements may be a result of
the feedback from the measurement process itself. This
theory relates to the quality improvement maxim that
“efforts to improve quality require efforts to measure it”
[20]. To be sure, during the past decade of quality assess-
ment of healthcare in Israel, health plans have implemen-
ted strategies for improving care and access to services as
well as encouraged physician adherence to guidelines
[21,22]. The dramatic increases in documentation of
anthropometric measures signify a targeted approach by
health plans to document a neglected area of care and
signal policy changes that have permeated all segments of
the healthcare system. In light of these observations,
expected trajectories of existing quality indicators are
likely to attenuate over the next decade.
It should be noted, however, that incentives may
account for lower rates of healthcare quality in certain
areas in comparison to England’s pay-for-performance
system since the Israeli healthcare system is not a pay-
for-performance system and physicians do not receive
direct benefits for increased performance. In order to
properly assess and compare the quality of Israel’s health-
care system with that of a pay-for-service, outcome-based
indicators and sufficient follow-up time are necessary.
Policy implications and future directions of this program
mirror that of other international efforts [23,24]. Quality
indicators must undergo constant evaluation of whether
they accurately capture the care that is being provided as
well as their impact on health outcomes [24]. Examination
of the adverse or beneficial changes in health outcomes is
an essential tool in the evaluation process, since change
alone in quality of care does not necessarily correspond to
improvements in patient health. Composite indicators of
health are also integral to disease management and future
indicator sets should comprise such measures.
Assessment of quality indicators should comprise a
more refined evaluation of subgroups and at-risk popula-
tions as well as changes over time in their quality care. In
a recent report by Hussey et al. [10], similar disparities in
socio-economic status (SES) in healthcare quality indica-
tors were observed for four countries with different health
systems and populations. The authors note that their
study underscores the need to examine the impact of
internal and external factors on the healthcare system
(and health inequalities), such as changing healthcare pat-
terns (internal) and targeted prevention programs (exter-
nal). The proxy SES variable available to the QICH data
set (data not shown) is of questionable utility and a proper
assessment of the effect of SES on quality care in Israel is
needed.
Finally, The QICH program has brought about substan-
tial positive changes in the quality of healthcare data in
Israel. An improved data platform that captures a larger
share of the healthcare delivery system is necessary for the
further assessment of continuity of care and other health-
care quality issues. Policymakers should promote the con-
tinued interface between the four Israeli health plans and
support communication with other healthcare providers,
such as for residential, early childhood and elderly care
facilities. Interchange between hospital and primary care is
vital to improved healthcare quality such as effectiveness
and efficiency of care and care coordination. This type of
improved framework requires policy changes and even
incentives to allow for information exchange and data flow
within the confines of privacy and confidentiality.
Strengths and limitations
Israel is one of the only countries with a systematic and
comprehensive evaluation program assessing the quality
of the community healthcare at a national level. The
QICH indicator set represents a unique and essential tool
in healthcare. First, quality indicators are important to
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assess adherence of the community healthcare system to
recommended guidelines that include preventive care.
Increased use of preventive healthcare services is consid-
ered essential for reducing the clinical preventable bur-
den as well as being cost effective [25]. Second, electronic
health records - a mainstay of the medical system in
Israel for over a decade, allow for the assessment of his-
torical as well as current healthcare measurements.
Third, all residents have unique identifying numbers that
allow for linking external medical records, such as those
for hospital procedures. Fourth, the program is a com-
bined effort of all four health plan providers, who have,
among other things, standardized disease registries and
confirmed their commitment to treatment guidelines.
These quality indicators are not without limitations.
Quality of community healthcare is anchored in its gov-
erning bodies and provider system and is susceptible to
the constraints and shortcomings of each. International
comparisons with similar measures are subject to the
diversity of policy, culture and resources that directly
and indirectly affect the structure, performance and out-
come of healthcare [26]. In Israel, health plans are
restricted by the availability of certain types of health-
care data, such as hospital discharge data and inpatient
diagnoses. For example, patients with heart disease are
identified using reimbursement codes for bypass surgery
or coronary angioplasty even though this sub-population
represents only about 10% of the patients with cardio-
vascular disease. The validity of the QICH indicator set
must also be qualified. Apart from laboratory results,
which produce objective and non-biased values, blood
pressure measurements, for example, which require
human assessment and documentation, vary between
testers and may be subject to dishonest reporting. Lastly,
regulatory restrictions of demographic information,
including socio-economic status, limit the development
of a complete assessment of quality across all categories
of health and for various subgroups. Case-mix adjust-
ments or stratification according to demographic or
socio-economic characteristics may allow for a clearer
understanding of the quality of health care in Israel in
order to target gaps in care and identify and learn from
successes.
Conclusions
The overall quality of community health care in Israel
has improved over the past three years. Comparisons
with similar international quality indicators suggest that
community healthcare in Israel is on par with other
Western countries. The results presented in this study
illustrate that the current state of health care in Israel is
that of improving quality of community healthcare. One
of the next steps in assessing and improving healthcare
quality in Israel is to relate these process and perfor-
mance indicators to health outcomes.
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